Clinical Trial Update: Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide plus ofatumumab in previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma; completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Fatigue | Phase 2 | Status: COMPLETED | Results posted: 2019-05-07